Home/Filings/4/0001123292-18-000970
4//SEC Filing

Harness Jane A. 4

Accession 0001123292-18-000970

CIK 0001355250other

Filed

Sep 23, 8:00 PM ET

Accepted

Sep 24, 4:26 PM ET

Size

7.1 KB

Accession

0001123292-18-000970

Insider Transaction Report

Form 4
Period: 2018-09-01
Harness Jane A.
Vice President
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-09-01+172,987172,987 total
    Exercise: $0.40Exp: 2028-09-01Class A Common Stock (172,987 underlying)
  • Award

    Class A Common Stock

    2018-09-01+58,394169,126 total
Footnotes (2)
  • [F1]Represents restricted stock vesting in three equal annual installments beginning on September 1, 2019.
  • [F2]The option vests in three equal annual installments on September 1, 2019, 2020 and 2021.

Issuer

Innovation Pharmaceuticals Inc.

CIK 0001355250

Entity typeother

Related Parties

1
  • filerCIK 0001702800

Filing Metadata

Form type
4
Filed
Sep 23, 8:00 PM ET
Accepted
Sep 24, 4:26 PM ET
Size
7.1 KB